Back to Search
Start Over
Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues Regarding Dual HER2-Targeted Therapy
- Source :
- Breast Cancer: Basic and Clinical Research, Vol 2012, Iss 6, Pp 191-207 (2012)
- Publication Year :
- 2012
- Publisher :
- SAGE Publishing, 2012.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 11782234
- Volume :
- 2012
- Issue :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- Breast Cancer: Basic and Clinical Research
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.163e7b8ace7f4889b0e683a312f37c81
- Document Type :
- article